The cannabis industry has established its first footholds in Europe over the past six years – but what comes...
Up To Date
Backgrounds & Stories
So far, no gene and cell therapies have been approved to treat solid tumours. European Biotechnology spoke...
Isolating cells from whole blood or LRS cones carries the risk of red blood cell (RBC) contamination, which...
The regulatory situation regarding the trade of medicinal cannabis currently varies enormously from country to...
Effective bioprocess development starts with the targeted and time-saving generation of high-productivity...
The future of AAV vector-based therapies holds great promise if manufacturers can cope with the demand. While...
Share
